News About: Pharm. Industry
Pharmaceutical firms asked to submit management data
The Korea Pharmaceutical Manufacturers Association called on its member companies to submit their management-related data until October 7, through its circular letter delivered on Wednesday.
The association plans t...
Bacchus D to be sold as quasi-drug
The Korea Food and Drug Administration says that Dong-A Pharmaceutical’s Bacchus-D was reclassified into one of the quasi-drugs last month, although the company has pledged to provide Bacchus-F to retailers and Bacchu...
HanAll initiate Phase I trial for oral formulation of human growth hormone
HanAll BioPharma Co. said Thursday it has initiate Phase I trial in Seoul National University Hospital for orally available protease resistant human growth hormone (HL-032).
This clinical study is designed to compa...
Are drug firms’ countermeasures effective?
The domestic pharmaceutical community has vehemently protested against the government’s plan to cut drug prices by an average of 17 percent starting next year.
The chief executives of the Korea Pharmaceutical Manuf...
Dong-A seeks overseas expansion with Zydena
Dong-A Pharmaceutical Co. is ramping up its overseas expansion drive with Zydena to make it one of the leading erectile dysfunction treatments in a global arena.
Between September 26 and 28, the company held a pro...
Drug firms tackle business uncertainties ahead of 2012
Korean pharmaceutical companies are concerned over mounting external and internal business uncertainties, which have caused them to tighten their belts on their operations.
Industry experts say that the government’...
Dong-A, Green Cross see double-digit growth in sales
The third quarter sales of Dong-A Pharmaceutical Co. and Green Cross Corp. third quarter sales are expected to increase by 16.8 percent and 25 percent, respectively, compared to the same period last year, Eugene Inves...
29 listed drug firms see market value drop
The combined market value of the KOSPI-listed 37 pharmaceutical firms by assets reached 9.31 trillion won as of end of September, down 1.52 trillion won from the end of 2010 lingering uncertainties over the financial ...
Ahngook forges strategic tie-up with Astellas Korea
Ahngook Pharmaceutical said Friday that it has established a marketing and distribution partnership with Astellas Korea.
Under the deal, Ahngook is in charge of selling Astellas drugs using its extensive domestic ...
Dong-A to launch biosimilar plant in Songdo
Dong-A Pharmaceutical Co., the nation’s No.1 drug maker, said Thursday that it signed a memorandum of understanding (MOU) with Incheon Free Economic Zone (IFEZ) Authority to build and operate a a global biomedicine co...
